VivoSeq
Other

Indocyanine Green

0

Pipeline Programs

9

Active Trials

0

Companies Involved

Indocyanine Green is an early-stage landscape with 0 programs across 0 companies.

Pipeline Metrics

Competitive Density

25/100

Pipeline Velocity

15/100

Mech. Concentration

N/A

Completion Rate

89/100

Attrition Rate

6/100

Programs by Phase

No pipeline programs currently tracked for this disease.

Trial Status

32

clinical trials

Completed16 · 50%
Unknown status5 · 16%
Recruiting5 · 16%
Not yet recruiting3 · 9%
Terminated1 · 3%
Withdrawn1 · 3%
Other1 · 3%

Trial Activity

32 trials

Use of Indocyanine Green in Robotic Prostate Surgeries
Not yet recruiting··Phase 4·NCT05960149·200 enrolled
Page 1 of 3

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)